Feasibility of ambulatory standard pleurodesis V1
Research type
Research Study
Full title
Feasibility study of chest drain insertion and talc pleurodesis for malignant pleural effusion on an ambulatory basis
IRAS ID
330188
Contact name
Kevin Conroy
Contact email
Sponsor organisation
NHS North Tees and Hartlepool foundation Trust
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
Patients with malignant pleural disease often experience a significant symptom burden and a short life expectancy. The cornerstone of their treatment is relieving breathlessness by draining fluid from around the lungs and attempting to prevent further fluid build up. Inpatient chest drainage and talc pleurodesis remains the most successful method of stopping the fluid build up but this often requires an average hospital stay of four days. This can be an inappropriate length of time for this patient group. Our study would investigate whether this treatment could be provided on an outpatient, ambulatory basis and facilitate a greater quality of life.
We would assess deliverability of the trial protocol and collect patient feedback to see if our patients consider it an acceptable and worthwhile intervention.REC name
North East - Newcastle & North Tyneside 2 Research Ethics Committee
REC reference
23/NE/0146
Date of REC Opinion
13 Nov 2023
REC opinion
Further Information Favourable Opinion